Company Overview

Development Stage

About the Company

[Summary] Technology interprets life, love achieves health

Anhui Anke Biotechnology (Group) Co., Ltd. is located near Dashu Mountain in Hefei High-tech Zone. It is a national innovative pilot enterprise, a key high-tech enterprise under the National Torch Plan, a national "863" Program achievement industrialization base, and one of the first companies listed on China's ChiNext board. The company specializes in the research, development, production, and sales of biological high-tech products such as cell engineering and genetic engineering. Its products cover biopharmaceuticals, chemically synthesized drugs, traditional and modern Chinese medicines, and diagnostic reagents. Leading products include the recombinant human interferon α-2b "Andaferon" series, recombinant human growth hormone "Ansomone", anti-sperm antibody detection (MAR method) kit "Ansibao", leptin, P185, etc., all independently developed, produced, and sold by Anke, selling well nationwide and exported to more than ten countries and regions.

Currently, Anke Biotechnology owns five wholly-owned subsidiaries: Anhui Anke Yu Liangqing Pharmaceutical Co., Ltd., Anhui Anke Hengyi Pharmaceutical Co., Ltd., Shanghai Suhaoyiming Co., Ltd., Wuxi Sino-German Meilian Biotechnology Co., Ltd., and Hefei Anke Precision Medicine Laboratory Co., Ltd., as well as two controlling subsidiaries: Anhui Xinkunhua Biomedical Engineering Co., Ltd. and Hefei Angao Information Technology Co., Ltd., and four participating companies: Boshengji Pharmaceutical Technology (Suzhou) Co., Ltd., Anke Clover Gene Technology Co., Ltd., Shanghai Xiyuan Biotechnology Co., Ltd., and Boshengji Anke Cell Technology Co., Ltd.

With the overall goal of creating a first-class domestic biomedical enterprise, the company has formulated a horizontal integration strategy with biomedicine as the main axis and Chinese and Western medicines and precision medicine as the two wings, promoting coordinated development under the "one main, two wings" approach, steadily advancing toward the grand goal of "century-scale Anke, century-old Anke." Anke sincerely invites aspiring talents to join us; we will provide a sufficiently broad platform to realize your great ambitions!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Anke Biotechnology Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 创业板
  • Deal: 深交所

Anke Biotechnology How Fast Is Hiring Growing? (61 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 9%
  • 2024: Down 36%
  • 2023: Up 83%
  • 2022: Up 64%
Anke Biotechnology Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Anke Biotechnology Campus Recruitment & Advanced Degree Talent Demand
Graduates 1 Master's 5 Doctorate 9
Note: How fast is hiring at Anhui Anke Biotechnology (Group) Co., Ltd. growing? Anke Biotechnology2025: 315 openings (up 9%), 2024: 289 openings (down 36%), 2023: 449 openings (up 83%), 2022: 246 openings (up 64%), 2021: 150 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Anke Biotechnology Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Down 23%
  • 2023: Up 8%
Anke Biotechnology Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Anhui Anke Biotechnology (Group) Co., Ltd. growing? Anke BiotechnologyMaster's recruitment over the years: 2025: 10 openings (flat), 2024: 10 openings (down 23%), 2023: 13 openings (up 8%), 2022: 12 openings.

Anke Biotechnology Doctoral Degree Job Demand Analysis

(More)
+350%
Growth Rate
2026 vs 2025
Anke Biotechnology Doctoral Hiring by Year: 2026 — 7 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Anhui Anke Biotechnology (Group) Co., Ltd. growing? Anke BiotechnologyDoctorate recruitment over the years: 2026: 9 openings (down 10%), 2025: 2 openings (flat).

Anke Biotechnology R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Anhui Anke Biotechnology (Group) Co., Ltd.? Based on an analysis of Anke Biotechnology's job postings over the past year, "医疗卫生/美容保健类" demand: 30.7%, "计算机/网络/技术类": 7.1%, "生物/制药/化工/环保类": 3.7%, "美术/设计/创意类": 1.5%, "科研类": 1.2%, "其他(研发和技术类)": 0.9%. For reference only.

Anke Biotechnology — What Are the Salaries Like? (323 records)

Manage
salary range: 4.5K - 50K, 49.2% of roles pay ¥6-10K
Note: salary statistics are based on 323 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Anhui Anke Biotechnology (Group) Co., Ltd.?Anke Biotechnology49.2% of positions earn 6-10K, Fresh graduate salary: ¥8.0K。销售类 average salary ¥11.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Anke Biotechnology

(More)
Are salaries high at Anhui Anke Biotechnology (Group) Co., Ltd.? We provide: 医药代表,销售,临床,护士,推广,产品经理,运营,药学,医生助理,教育专员,信息,儿科,学术专员,总经理,bd,人力,客服,cmo,文案,法务. Click to view detailed salary analysis by job.

Anke Biotechnology honors, qualifications & industry associations

Anke Biotechnology Related Industry Tags

Job Category

  • 销售类
    51.7% of total 51.7%
  • 医疗卫生/美容保健类
    30.7% of total 30.7%
  • 经营管理类
    14.2% of total 14.2%
  • 客户服务类
    11.5% of total 11.5%

Education

  • 本科
    61% of total 61%
  • 大专
    28.8% of total 28.8%
  • 硕士
    4.3% of total 4.3%
  • 博士
    3.1% of total 3.1%

Experience

  • 1-3年
    37.8% of total 37.8%
  • 不限
    37.2% of total 37.2%
  • 5-10年
    14.2% of total 14.2%
  • 3-5年
    10.2% of total 10.2%
View Detailed Analysis

What does Anhui Anke Biotechnology (Group) Co., Ltd. require? Who is Anke Biotechnology hiring? Anke Biotechnology recruitment: 销售类占比最多占51.7%,其次是医疗卫生/美容保健类占30.7%. What education can get in at Anke Biotechnology? 本科占比最多占61%,其次是大专占28.8%. High education required at Anke Biotechnology? 硕士占4.3%,博士占3.1%. Work experience required at Anke Biotechnology? 1-3年占比最多占37.8%,其次是不限占37.2%. Where are the job locations at Anke Biotechnology? 合肥占比最多占30.3%,其次是上海占4.3%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 167,255.3658万(元)
Legal Representative: 宋礼华
Date Established:
Credit Code: 91340100149030777L
Registered Address: 安徽省合肥市长江西路669号高新区海关路K-1

Anke Biotechnology Featured in the Following Albums (More)

Partners & Suppliers

安科生物的基因工程药物在安徽市场通过华康医药销售 Source
合作客户 生物制品
提供药品及中间体检测服务 Source
供应商 食品检测
为安科生物的新冠病毒检测试剂等产品提供注册检验服务 Source
供应商 检测服务客户
共建生物医药研发平台,推进创新药物研发 Source
合作客户 生物医药
采购冻干粉针及固体制剂设备 Source
供应商 生物制药企业

People who follow Anke Biotechnology also follow

Anke Biotechnology Competitors (Similar Companies)

“Top 100 comprehensive strength enterprises in China's chemical pharmac”
“Experts in global pharmaceutical and healthcare”
制药/药业 医药 口服固体制剂 CDMO
医药流通 医药商业 代理分销 产品分销
制药/药业 疫苗 生物制品研发 医药
制药/药业 生物制药 化学合成药 肝素钙
医药 生物制品 生物医药 疫苗
生物科技/生物工程 食品添加剂 氨基酸 添加剂
医药流通 医药商业 零售 医药配送
“肿瘤药物开发机构”
“专注研发,助力安全有效的医药类产品守护人类健康。”
“珍惜生命,呵护健康,做好药,为百姓”
“Empowering the information society with storage technology, improving ”
药物研发 新药研发 抗肿瘤药 化学合成药
医疗科技 宫颈癌筛查 原料 出口

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates